TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26771632

Group type: EXPERIMENTAL
Intervention: Folic acid and betaine supplementation with wine
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Vitamin B12 supplementation with wine
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Vitamin B6 supplementation with wine
Number of subjects: 117

Group type: COMPARATOR
Intervention: Wine-only group (control)
Number of subjects: 117
Study: 24588066

Group type: EXPERIMENTAL
Intervention: Adjunctive emotion regulation group therapy (ERGT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Treatment-as-usual only waitlist condition
Number of subjects: 51
Study: 22387276

Group type: EXPERIMENTAL
Intervention: DCD-training (soccer training for 10 weeks)
Number of subjects: 51

Group type: COMPARATOR
Intervention: DCD non-training
Number of subjects: 51

Group type: COMPARATOR
Intervention: Typically developing (TD) children
Number of subjects: 51
Study: 20737164

Group type: EXPERIMENTAL
Intervention: Pulse-matched trains at 100 pulses delivered at 7.5, 15, 25, 30, 50, and 100 Hz
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Trains of varying pulse number (50, 100, and 200 pulses) at 30 and 50 Hz
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Highest frequency train (100 Hz)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Force-time integral produced by the stimulation train
Number of subjects: 10
Study: 18936595

Group type: EXPERIMENTAL
Intervention: Occlusal splint (OS) therapy used at nighttime and for 3 hours during daytime for 7 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Occlusal splint (OS) therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no stomatognathic intervention)
Number of subjects: 20
Study: 16087791

Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg twice daily for 1 week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12585182

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM) plus human chorionic gonadotropin and progesterone
Number of subjects: 23

Group type: COMPARATOR
Intervention: Multi-vitamin only
Number of subjects: 23
Study: 10352202

Group type: EXPERIMENTAL
Intervention: Intradialytic parenteral nutrition (IDPN) with amino acids (AAs)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Intradialytic parenteral nutrition (IDPN) without amino acids (AAs)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Intradialytic parenteral nutrition (IDPN) with all three components (AAs, dextrose, lipids)
Number of subjects: 19

Group type: COMPARATOR
Intervention: IDPN withheld
Number of subjects: 19
Study: 7488807

Group type: EXPERIMENTAL
Intervention: 25,000 IU of vitamin A
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study: 1779314

Group type: EXPERIMENTAL
Intervention: Improved ORS (20 g maltodextrin, 4 g glycine, 4 g glycyl‐glycine)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard ORS (WHO formulation containing citrate)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Improved ORS
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard ORS
Number of subjects: 101
Study: 6755855

Group type: EXPERIMENTAL
Intervention: Bacillus Calmette-Guerin (BCG) adjuvant immunotherapy plus conventional therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Bacillus Calmette-Guerin (BCG) adjuvant immunotherapy
Number of subjects: 42
Study: 30864254

Group type: EXPERIMENTAL
Intervention: Combined resistance exercise and nutritional supplementation (protein and vitamin D)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 112

Group type: COMPARATOR
Intervention: Nutritional supplementation alone (protein and vitamin D)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 112
Study: 28122783

Group type: EXPERIMENTAL
Intervention: Folic acid treatment (0.8 mg daily)
Number of subjects: 20327

Group type: COMPARATOR
Intervention: Enalapril alone (10 mg daily)
Number of subjects: 20327
Study: 26904965

Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 7112

Group type: EXPERIMENTAL
Intervention: Gastrointestinal surgery
Number of subjects: 7112

Group type: EXPERIMENTAL
Intervention: Severe PONV
Number of subjects: 7112
Study: 24299323

Group type: EXPERIMENTAL
Intervention: Pantoprazole-Mg 40 mg once daily
Number of subjects: 578

Group type: COMPARATOR
Intervention: Esomeprazole 40 mg once daily
Number of subjects: 578
Study: 22876396

Group type: EXPERIMENTAL
Intervention: Alcohol-based (AB) 0.1% chlorhexidine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Alcohol-free (AF) 0.12% chlorhexidine
Number of subjects: 20
Study: 19647661

Group type: EXPERIMENTAL
Intervention: Needle bevel position bevel up
Number of subjects: 50

Group type: COMPARATOR
Intervention: Needle bevel position bevel down
Number of subjects: 50
Study: 17699180

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 16483490

Group type: EXPERIMENTAL
Intervention: IDA (n = 77)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Zevodas (n = 78)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: IDA (n = 77) in AML patients
Number of subjects: 155

Group type: COMPARATOR
Intervention: Zevodas (n = 78) in AML patients
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: IDA (n = 77) in ALL patients
Number of subjects: 155

Group type: COMPARATOR
Intervention: Zevodas (n = 78) in ALL patients
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: IDA and Zevodas
Number of subjects: 155
Study: 12421192

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 10 mg/kg given at conclusion of surgery and again 3 hours later
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-TXA (control group)
Number of subjects: 30
Study: 10510140

Group type: EXPERIMENTAL
Intervention: Budesonide 400 microg twice daily
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Budesonide 800 microg twice daily
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Budesonide 1600 microg twice daily
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Budesonide (all doses)
Number of subjects: 38
Study: 7717564

Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia
Number of subjects: 18

Group type: COMPARATOR
Intervention: Isoflurane anesthesia
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Desflurane and Isoflurane anesthesia
Number of subjects: 18
Study: 1851688

Group type: EXPERIMENTAL
Intervention: 100 mmol of sodium/day diet
Number of subjects: 7

Group type: COMPARATOR
Intervention: 20 mmol of sodium/day diet
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 7
Study: 7128221

Group type: EXPERIMENTAL
Intervention: Digoxin 0.25 mg/day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29454369

Group type: EXPERIMENTAL
Intervention: Piezocision (PG)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Laser-assisted flapless corticotomy (LG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control side (for both PG and LG)
Number of subjects: 36
Study: 24469619

Group type: EXPERIMENTAL
Intervention: Endovascular Aneurysm Repair (EVAR)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Open Repair (OR)
Number of subjects: 116
Study: 21971628

Group type: EXPERIMENTAL
Intervention: Training program of 16 sessions of 2.5 hours each over 4 months
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 69
Study: 20522079

Group type: EXPERIMENTAL
Intervention: Vitex agnus castus (VAC, BNO 1095)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 18672986

Group type: EXPERIMENTAL
Intervention: 0.6% eucalyptus extract chewing gum for 12 weeks (90 mg/day)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 0.4% eucalyptus extract chewing gum for 12 weeks (60 mg/day)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo chewing gum without eucalyptus extract for 12 weeks
Number of subjects: 97
Study: 16551899

Group type: EXPERIMENTAL
Intervention: Milrinone initial dose of 100 or 250 microg/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Continuous IV infusion of milrinone at 0.5 microg x kg(‐1) x min(‐1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Postoperative milrinone clearance
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Infusion rate of milrinone at 0.2 microg x kg(‐1) x min(‐1)
Number of subjects: 16
Study: 14666758

Group type: EXPERIMENTAL
Intervention: Shenmai Injection (SI)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Routine treatment + SI
Number of subjects: 62

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 62
Study: 10700663

Group type: EXPERIMENTAL
Intervention: buspirone 0.14 mg/kg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: buspirone 0.28 mg/kg
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: other measures of REM sleep
Number of subjects: 14
Study: 8777883

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 170

Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 170
Study: 1988669

Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg 3 times daily)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6802235

Group type: EXPERIMENTAL
Intervention: Postoperative isotope liver scan
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Postoperative ultrasonography
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Postoperative computed tomography
Number of subjects: 43
Study: 31494096

Group type: EXPERIMENTAL
Intervention: 150 mg AMG 714
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 300 mg AMG 714
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 28735698

Group type: EXPERIMENTAL
Intervention: Childhood ADHD symptoms, IQ, and household income levels
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Childhood demographic, clinical, and family factors
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Baseline ADHD severity, IQ, comorbidity, family income, number of household members, parental education, parental monitoring, parental marital problems
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Timely treatments for ADHD symptoms and additional support for children with lower IQ and from low-income households
Number of subjects: 837
Study: 25245863

Group type: EXPERIMENTAL
Intervention: Microscope
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Magnifying glasses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unsupported vision
Number of subjects: 0
Study: 23770889

Group type: EXPERIMENTAL
Intervention: Trampoline exercise intervention (daily individualized 20-min sessions for 12 weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Regular school schedule (control group)
Number of subjects: 18
Study: 21794162

Group type: EXPERIMENTAL
Intervention: Post-test counseling by trained counselors and monthly home visits by community support agents
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard care (existing post-test counseling by ARV clinic staff who lack basic training in counseling skills)
Number of subjects: 400
Study: 18464801

Group type: EXPERIMENTAL
Intervention: Aspheric lenses (Tecnis, Cee-on Edge, Acrysof Natural, IQ)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Tecnis lens
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Aspheric lenses
Number of subjects: 30
Study: 17520385

Group type: EXPERIMENTAL
Intervention: Laparoscopic abdominoperineal resection
Number of subjects: 74

Group type: COMPARATOR
Intervention: Open abdominoperineal resection
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 74
Study: 15215792

Group type: EXPERIMENTAL
Intervention: Telmisartan and Ramipril combination
Number of subjects: 25620

Group type: COMPARATOR
Intervention: Telmisartan
Number of subjects: 25620
Study: 11239640

Group type: EXPERIMENTAL
Intervention: Extra-amniotic infusion of PGE2 (0.5 microg/mL)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Extra-amniotic infusion of saline
Number of subjects: 116
Study: 9569440

Group type: EXPERIMENTAL
Intervention: Septorhinoplasty patients
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 25
Study: 8072387

Group type: EXPERIMENTAL
Intervention: Graded doses of licorice (814 mg glycyrrhizin)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Graded doses of licorice (380 mg glycyrrhizin)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Graded doses of licorice (217 mg glycyrrhizin)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Graded doses of licorice (108 mg glycyrrhizin)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no licorice)
Number of subjects: 24
Study: 2468871

Group type: EXPERIMENTAL
Intervention: Nitrendipine (5-20 mg b.i.d.)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Propranolol (40-120 mg b.i.d.)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 274

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 274
Study: 31050048

Group type: EXPERIMENTAL
Intervention: Repetitions to failure (RFG)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Repetitions not to failure (NFG)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Equal training volume not to failure (ENFG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: All groups (RFG, NFG, ENFG)
Number of subjects: 36
Study: 27639785

Group type: EXPERIMENTAL
Intervention: Personalized multi-condition risk assessment (HRA)
Number of subjects: 3703

Group type: COMPARATOR
Intervention: Control group (risk perception assessment only)
Number of subjects: 3703
Study: 26385046

Group type: EXPERIMENTAL
Intervention: Exercise training (12-week standardized aerobic exercise program)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (lifestyle as usual)
Number of subjects: 93
Study: 23336506

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise (one hour every two days)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no Tai Chi exercise)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise
Number of subjects: 70
Study: 22040504

Group type: EXPERIMENTAL
Intervention: Lianhuaqingwen capsule (LHC)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Oseltamivir
Number of subjects: 244
Study: 19453758

Group type: EXPERIMENTAL
Intervention: Silymarin (140 mg three times a day) plus desferrioxamine
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo plus desferrioxamine
Number of subjects: 59
Study: 16405436

Group type: EXPERIMENTAL
Intervention: DTPA clearance using 35 mCi (1295 MBq) of Tc 99m-DTPA
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: DTPA clearance
Number of subjects: 43
Study: 15175216

Group type: EXPERIMENTAL
Intervention: Paper clip set
Number of subjects: 75

Group type: COMPARATOR
Intervention: Disk-Criminator
Number of subjects: 75
Study: 11471852

Group type: EXPERIMENTAL
Intervention: Imidapril 5 ‐ 10 mg/day
Number of subjects: 320

Group type: COMPARATOR
Intervention: Nifedipine SR 20 ‐ 40 mg twice daily
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Imidapril
Number of subjects: 320

Group type: COMPARATOR
Intervention: Nifedipine SR
Number of subjects: 320
Study: 9627123

Group type: COMPARATOR
Intervention: HLA allele DQB1*0302
Number of subjects: 46

Group type: COMPARATOR
Intervention: HLA allele DQB1*0402
Number of subjects: 46
Study: 8161627

Group type: EXPERIMENTAL
Intervention: Tunneled catheters (TCs)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Nontunneled catheters (NTCs)
Number of subjects: 169
Study: 3348161

Group type: EXPERIMENTAL
Intervention: 10 mg ferrous sulfate.kg‐1.d‐1 for 12 weeks
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo treatment for 12 weeks
Number of subjects: 119
Study: 28809582

Group type: EXPERIMENTAL
Intervention: Iodixanol 270
Number of subjects: 306

Group type: COMPARATOR
Intervention: Iopromide 300
Number of subjects: 306
Study: 28566173

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (14,000 IU/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 40
Study: 26232348

Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine (IIV)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Live attenuated influenza vaccine (LAIV)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Combined (IIV and LAIV)
Number of subjects: 166
Study: 23820968

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided adductor canal block with 0.5% ropivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham subcutaneous injection of sterile saline
Number of subjects: 50
Study: 20956393

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 18494215

Group type: EXPERIMENTAL
Intervention: Regular moderate-intensity exercise training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard measures (Control)
Number of subjects: 60
Study: 17058517

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg once daily (n = 90)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg once daily (n = 90)
Number of subjects: 180
Study: 12560228

Group type: EXPERIMENTAL
Intervention: Left-sided CVL
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Subclavian CVL
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Percutaneous CVL insertion
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Subclavian vein CVL inserted percutaneously
Number of subjects: 85

Group type: COMPARATOR
Intervention: CVL placement on the right side and in the jugular vein
Number of subjects: 85

Group type: COMPARATOR
Intervention: Subclavian vein placement with venous cut-down
Number of subjects: 85
Study: 11816746

Group type: EXPERIMENTAL
Intervention: Psychological factors (depression, anxiety, type A behavior)
Number of subjects: 0
Study: 9716056

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin suspension (10 mg/kg every 12 h for 5 days, maximum individual dose 500 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pivmecillinam tablets (15-20 mg/kg every 8 h for 5 days, maximum individual dose 300 mg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin suspension
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pivmecillinam tablets
Number of subjects: 120
Study: 7979041

Group type: EXPERIMENTAL
Intervention: Inflated tissue expanders
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Deflated tissue expanders
Number of subjects: 50

Group type: COMPARATOR
Intervention: Displaced view with inflated implants
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Deflated adjustable implants
Number of subjects: 50
Study: 2722728

Group type: EXPERIMENTAL
Intervention: cefoxitin sodium (30 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: cefmetazole sodium (15 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: cefmetazole sodium (30 mg/kg)
Number of subjects: 30
Study: 48347

Group type: EXPERIMENTAL
Intervention: Hydromorphone 1 mg
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Hydromorphone 2 mg
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Hydromorphone 0.5 mg
Number of subjects: 143

Group type: COMPARATOR
Intervention: Morphine 5 mg
Number of subjects: 143

Group type: COMPARATOR
Intervention: Morphine 10 mg
Number of subjects: 143
Study: 31307524

Group type: EXPERIMENTAL
Intervention: UGSJB granule with acupuncture, twice daily
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo with acupuncture, twice daily
Number of subjects: 240
Study: 28372556

Group type: EXPERIMENTAL
Intervention: Central Concentrate System (CCS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Pre-produced bicarbonate concentrates (PPC)
Number of subjects: 16
Study: 26135463

Group type: EXPERIMENTAL
Intervention: Continuous infusion (cIV) of 160 mg furosemide for 16 h/day (n=15)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Bolus injections (bI) of 80 mg furosemide twice a day (n=14)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Furosemide plus hypertonic saline solution (HSS) as an infusion for 30 min once a day (n=14)
Number of subjects: 43
Study: 23066720

Group type: EXPERIMENTAL
Intervention: Methotrexate (0.4 mg/kg weekly)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Acitretin (0.5 mg/kg daily)
Number of subjects: 111
Study: 21247300

Group type: EXPERIMENTAL
Intervention: Cognitive model for advance care planning discussions implemented in a quality improvement project
Number of subjects: 0
Study: 18451394

Group type: EXPERIMENTAL
Intervention: Uncovered trays in room with traffic
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Uncovered trays in room without traffic
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Covered trays with sterile towel
Number of subjects: 45
Study: 16601628

Group type: EXPERIMENTAL
Intervention: Home-based intervention to improve behavioral symptoms and caregiver self-efficacy
Number of subjects: 42
Study: 12951131

Group type: EXPERIMENTAL
Intervention: Direct training with stimuli (dictated words, pictures, printed words)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observing a model without disabilities demonstrating conditional discriminations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct training with stimuli in three sets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observing a model's training with stimuli in three different sets
Number of subjects: 0
Study: 10855154

Group type: EXPERIMENTAL
Intervention: Home-based preoperative bowel preparation with home care services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home-based preoperative bowel preparation without home care services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hospital-based preoperative bowel preparation
Number of subjects: 0
Study: 9096986

Group type: EXPERIMENTAL
Intervention: Glipizide GITS (5, 20, 40, or 60 mg)
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Glipizide GITS (5, 10, 15, or 20 mg)
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Glipizide GITS
Number of subjects: 347

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 347